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Abstract
Background: Oxidative stress has been implicated in the pathogenesis of a wide spectrum of human diseases,
including Hepatitis B virus (HBV)-related liver disease. Hepatitis B virus X protein (HBx) is a key regulator of HBV that
exerts pleiotropic activity on cellular functions. Recent studies showed that HBx alters mitochondrial membrane
potential, thereby sensitizing cells to pro-apoptotic signals. However, it remains largely unknown whether
susceptibility of hepatocytes could be disturbed by HBx under oxidative stress conditions. The purpose of this
study is to determine the apoptotic susceptibility of HBx-expressing hepatocytes upon exposure to pro-oxidant
stimuli in vitro and in vivo and explore its underlying mechanism.
Results: Although expression of HBx itself did not activate apoptotic signaling, it significantly enhanced oxidative
stress-induced cell death both in vitro and in vivo. Interestingly, this phenomenon was associated with a
pronounced reduction of protein levels of Mcl-1, but not other anti-apoptotic Bcl-2 members. Importantly,
enforced expression of Mcl-1 prevented HBx-triggered cell apoptosis; conversely, specific knockdown of Mcl-1
exacerbated HBx-induced apoptosis upon exposure to oxidative stress. Furthermore, inhibition of caspase-3 not
only abrogated HBx-triggered apoptotic killing but also blocked HBx-induced Mcl-1 loss. Additionally, expression of
HBx and Mcl-1 was found to be inversely correlated in HBV-related hepatocellular carcinogenesis (HCC) tissues.
Conclusions: Our findings indicate that HBx exerts pro-apoptotic effect upon exposure to oxidative stress probably
through accelerating the loss of Mcl-1 protein via caspase-3 cascade, which may shed a new light on the
molecular mechanism of HBV-related hepatocarcinogenesis.
Background
Chronic Hepatitis B virus (HBV) infection is a major
risk factor of human chronic liver disease and is strongly
associated with hepatocellular carcinogenesis (HCC).
A m o n gt h eH B Ve n c o d i n gp r o t e i n s ,H B VXp r o t e i n
(HBx) is considered as a critical viral protein that exhi-
bits multifunctional activities in modulating gene tran-
scription, protein degradation, signal transduction, cell
proliferation, cell cycle progress, senescence, autophagy
and apoptosis [1-4].
Since apoptosis has been implicated as an important
mechanism for liver injury [5,6], much effort has been
made to understand the role of HBx in the regulation of
a p o p t o s i sa n di t sc o n t r i b u t i o nt oH C C .T od a t e ,t h e
reported effects of HBx on apoptosis are controversial.
As reported previously, the discrepancy of the role of
HBx on cell apoptosis may be due to the different cul-
ture conditions and experimental systems used in these
studies. Nevertheless, majority of these studies demon-
strated that HBx can induce cell death or sensitize hepa-
tocytes to a variety of apoptotic signals such as TNF-a,
TRAIL, vitamin K3, ethanol, Fas, and UV [7-12]. In
experimental animals, HBx transgenic mice also exhibit
increased hepatic apoptosis [13].
It is well known that oxidative stress have been impli-
cated in the pathogenesis of inflammatory diseases and
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tinuously generated within chronic inflammation and
malignant tumor tissues. In addition, infiltration of acti-
vated phagocytic cells in liver disease provides another
source of ROS production that promotes oxidative
damage to hepatocytes [15]. Recent work showed that
HBx expression could alter mitochondrial membrane
potential and increase cellular ROS production, thereby
sensitizing hepatoma cells to apoptotic stimuli [9,16].
Consistent with these in vitro findings, HBV transgenic
mice also display elevated oxidative stress levels in the
liver as compared to the nontransgenic control strain
[17]. Thus, it is possible that, in HBV-infected liver,
HBx protein and oxidative signals generated within the
microenvironment may cooperate to increase cellular
ROS accumulation up to a deleterious level, thereby
resulting in overt liver cell damage. However, relatively
little research has addressed the issue of whether sus-
ceptibility of hepatocytes upon exposure to oxidative
stress could be affected by HBx.
The Bcl-2 protein family plays a pivotal role for
mitochondrial membrane integrity and apoptosis regu-
lation [18,19]. Among them, Mcl-1 is both structurally
and functionally an anti-apoptotic member of the Bcl-2
family. It mainly locates on the outer membrane of
mitochondria and is an important regulator of mito-
chondria-mediated apoptosis by preventing the release
of cytochrome c into cytosol [20]. Recently, it has been
demonstrated that Mcl-1 plays a key role in regulation
of apoptosis and survival in multiple tissues and cell
lines [21,22]. It is frequently overexpressed in several
human malignancies such as multiple myeloma, non-
small cell lung cancer and HCC. Knock down Mcl-1
protein expression sensitizes HCC cells towards apop-
tosis induction [23,24]. Using a conditional knock-out
animal model, Schulze-Bergkamen H and his team
demonstrated that hepatocyte-specific deletion of Mcl-
1 not only increases spontaneous hepatocyte apoptosis
resulting in profound liver cell damage and increases
susceptibility of hepatocytes to pro-apoptotic stimuli
[25], but also, more importantly, triggers hepatocellular
proliferation and causes HCC [26]. Results from pre-
vious studies showed that H2O2 could abrogate the
prosurvival function of Mcl-1 either by diminishing its
levels or by inactivating its function [27,28], however,
little is known about the potential role of Mcl-1 in
HBx-induced cell killing. Given the importance of
Mcl-1 in maintaining liver homeostasis, the aim of this
work was to determine the apoptotic susceptibility of
HBx-expressing hepatocytes under oxidative stress
conditions and explore the possible role of Mcl-1 in
this process.
Here, we reported that HBx enhanced oxidative stress-
induced apoptotic killing both in vitro and in vivo,w h i c h
is probably through accelerating the loss of Mcl-1 protein
via caspase-3 cascade. Our results may have implications
for understanding HBV-related hepatocarcinogenesis.
Results
HBx-Tg mice exhibit an increased oxidative stress and
apoptotic susceptibility to liver ischemia-reperfusion
challenge
To investigate whether susceptibility of hepatocytes
under oxidative stress conditions could be disturbed by
HBx in vivo, HBx transgenic (HBx-Tg) mice and wide
type (WT) control strain were used (Figure 1A) and sub-
jected to warm liver ischemia-reperfusion (I/R), an ani-
mal model which mimics pro-oxidant milieu in vivo.A s
expected, a decrease in total liver GSH level, an indicator
of hepatocyte ROS accumulation, was observed in I/R-
treated WT mice. Notably, an even greater decrease in
liver GSH content was detected in I/R-treated HBx-Tg
mice (Figure 1B). As an important index of oxidative
stress, liver GSH/GSSG ratio were also monitored. Simi-
larly, liver I/R treatment caused an even greater dramatic
fall in the GSH/GSSG ratio in HBx-Tg mice than WT
m i c e( F i g u r e1 B ) .T oe v a l u a t e in situ formation of ROS,
the oxidative fluorescent dye dihydroethidine (DHE) was
used by a method described by Sakurai T et al [29]. More
extensive fluorescence was seen in livers of HBx-Tg mice
than matched controls after liver I/R treatment (Figure
1C), indicating that HBx promotes cellular ROS accumu-
lation upon oxidative stress stimulation. Meanwhile,
increased hepatocyte apoptosis, as determined by PARP
cleavage, was also observed in livers of HBx-Tg mice as
compared to WT mice following I/R challenge (Figure
1D). To further evaluate hepatocyte apoptosis in the
liver, a TUNEL-based immunohistochemistry assay was
performed. Consistently, livers from HBx-Tg mice exhib-
ited a pronounced accumulation of TUNEL-positive cells
compared with those from WT mice following I/R treat-
ment (Figure 1E). These findings confirm that HBx-Tg
mice are more susceptible to oxidative stress-induced
hepatocyte apoptosis.
To evaluate whether increased oxidative stress contri-
bute to the pro-apoptotic effect of HBx, mice were
given antioxidant butylated hydroxyanisole (BHA)-con-
taining (0.7%) or control chow for 2 days and then chal-
lenged with liver I/R. Importantly, BHA administration
not only restored the liver GSH content and GSH/
GSSG ratio and reduced DHE-stained cells in I/R-trea-
ted HBx-Tg mice to a level similar to matched controls,
but also effectively abrogated increased cell apoptosis in
livers of I/R-challenged HBx-Tg mice (Figure 1B, C and
1D). Furthermore, histological analysis revealed that
BHA treatment almost completely blocked appearance
of TUNEL-positive hepatocytes in I/R-treated HBx-
Tg mice (Figure 1E). Thus, HBx enhances oxidative
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depend on ROS accumulation.
HBx enhances cellular ROS production and sensitizes
hepatocytes to H2O2-induced apoptosis
To further confirm the in vivo data, we employed HBx-
expressing stable HepG2 (HepG2-HBx) cells and empty
vector (HepG2-con) counterparts as described previously
[30]. Consistent with our in vivo results, H2O2 exposure
resulted in an increase in ROS levels in HepG2-con cells,
but under the same condition, much more ROS-positive
cells were seen in H2O2-exposed HepG2-HBx cells than
control cells (Figure 2A). To examine whether the effect
of HBx on ROS accumulation reflects the events in HBV-
infected cells, we compared the ROS levels in parental
HepG2 cells with HepG2.2.15 cells that constitutively
replicated HBV upon exposure to H2O2. Similarly,
HepG2.2.15 cells also exhibited a greater percentage of
ROS-positive cells than parental HepG2 cells (Figure 2A).
To explore the role of ROS in the mechanism of HBx-
sensitized cell apoptosis, cells were treated with H2O2 in
concentrations from 100 to 400 μM. HBx-mediated cell
death was found to increase after H2O2 exposure in a
dose-dependent manner (Figure 2B). To evaluate the
potential dose-effect relationship between HBx and apop-
totic killing, a recombinant Myc-tagged HBx-expressing
adenoviral system was used as described previously [30].
As expected, adenovirus-mediated gene transfer of HBx
dose-dependently increased the susceptibility of HepG2
cells toward H2O2-induced apoptosis (Figure 2C).
Despite the evidence that apoptosis was apparent in
the HBx-expressing cells, it is not sufficient to reflect
Figure 1 HBx-Tg mice exhibit an increased oxidative stress and susceptibility to liver ischemia-reperfusion challenge. (A) The transcript
of HBx in livers from HBx-Tg or wide type (WT) mice was detected using RT-PCR. (B) Mice were given butylated hydroxyanisole (BHA)-containing
(0.7%) or control diet for 2 days and then subjected to 60 min of warm liver ischemia (see “Materials and Methods”), followed by 6 hr of
reperfusion before sacrificed. Total liver GSH content and GSH/GSSG ratio were determined. Values are mean ± SD (n = 4). *, p < 0.05. (C) Frozen
liver sections from mice treated as in Fig. 1B were subjected to dihydroethidine (DHE) staining. Representative results are shown. Magnification,
×100. (D) Livers from mice treated as in Fig. 1B were homogenized and the protein levels of PARP and GAPDH were determined by Western
blot assay. GAPDH was used as a loading control. (E) Liver sections from mice treated as in Fig. 1B were subjected to TUNEL and HE staining.
Representative results are shown. Magnification, ×100.
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HBx expression is usually low in HBV-infected cells and
tissues. Therefore, we examined the apoptotic suscept-
ibility of HepG2.2.15 cells upon oxidative stress stimula-
tion. Consistently, H2O2 treatment induced significant
apoptotic killing in HepG2.2.15 cells as compared to
control cells (Figure 2D), supporting an apoptosis-
promoting activity of HBV under oxidative stress condi-
tions. To further determine whether HBx is required for
HBV-induced cell death, SMMC-7721 cells were trans-
fected with the p3.8II plasmid containing the wild-type
HBV genome or with p3.8IIxm, an HBx-mutated HBV
genome and then challenged with H2O2 stress. Strik-
ingly, p3.8II-transfected cells showed an increased
Figure 2 HBx enhances production of cellular ROS and sensitizes hepatocytes to H2O2-induced apoptosis. (A) Indicated cells were
treated with or without H2O2 (400 μM) for 15 hr and then incubated with DCFH-DA for 30 min and the production of ROS was determined.
Representative results are shown. Magnification, ×100. (B) Cells were exposed to the indicated amount of H2O2 for 15 hr and the protein levels
of PARP, caspase-3, HBx and GAPDH were determined by Western blot assay. “ns”, nonspecific bands. (C) HepG2 cells were infected with Ad-
HBx-myc or Ad-blank at the indicated MOI for 36 hr followed by treated with H2O2 (400 μM) for additional 15 hr. Expression of PARP, caspase-3,
Myc-tag and GAPDH was analyzed by Western blot assay. (D) HepG2.2.15 or HepG2 cells were treated with or without H2O2 (400 μM) for 15 hr
and protein levels of PARP, caspase-3 and GAPDH were measured by Western blot assay. (E) SMMC-7721 cells were transiently transfected with
p3.8II or p3.8IIxm for 36 hr followed by treated with or without H2O2 (400 μM) for additional 15 hr. Then cell lysates were subjected to Western
blot and probed with indicated antibodies.
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whereas p3.8IIxm-transfected cells showed significant
apoptosis resistance in response to H2O2 stimulation,
indicating that HBx is essential for HBV-induced apop-
totic killing.
Together, these in vitro and in vivo data confirm that
HBx enhances cellular ROS accumulation and triggers
apoptosis under conditions of oxidative stress.
HBx decreases the expression of the anti-apoptotic Mcl-1
protein upon oxidative stress stimulation
Next, we attempted to investigate the molecular events
responsible for HBx-enhanced cell death upon exposure
to oxidative stress. In view of the pivotal role that anti-
apoptotic Bcl-2 family members play in mitochondrial
integrity and hepatocyte survival [18,19], we examined
expression of three important anti-apoptotic Bcl-2
family proteins (Bcl-2, Mcl-1, and Bcl-xL) in response to
H2O2. Consistent with a previous report [31], Bcl-2 pro-
tein was not detected in hepatoma cell lines examined
(Figure 3). Interestingly, protein levels of Mcl-1 declined
significantly in HepG2-HBx cells compared with those
in HepG2-con cells after H2O2 treatment in a dose-
dependent manner, while Bcl-xL protein levels revealed
no substantial difference between HepG2-HBx and
HepG2-con cells (Figure 3A). In addition, ectopic
expression of HBx significantly reduced Mcl-1 expres-
sion in HepG2 and Huh-7 cells, but had no major effect
Figure 3 HBx decreases the expression of the anti-apoptotic Mcl-1 protein upon oxidative stress stimulation. (A) Cells were exposed to
the indicated amount of H2O2 for 15 hr and expression of Mcl-1, Bcl-xL, Bcl-2 and GAPDH was analyzed by Western blot assay. (B) HepG2 or
Huh-7 cells were infected with Ad-HBx-myc or Ad-blank at the indicated MOI for 36 hr followed by treated with H2O2 (400 μM) for additional 15
hr. Expression of Mcl-1, Bcl-xL, Myc-tag and GAPDH was analyzed by Western blot assay. (C) Cells were treated with or without H2O2 (400 μM)
for 15 hr and indicated proteins were determined by Western blot assay. (D) SMMC-7721 cells were treated as in Fig. 2E and indicated proteins
were determined by Western blot assay. (E) Livers from mice treated as in Fig. 1D were homogenized and protein levels of Mcl-1, Bcl-xL and
GAPDH were determined by Western blot assay.
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expression decreased greatly in HBV-replicating
HepG2.2.15 cells compared with that in parental HepG2
cells after treatment with H2O2 (Figure 3C), suggesting
that HBV may have a similar effect on Mcl-1 expression
as HBx does. Importantly, protein levels of Mcl-1 signif-
icantly reduced in p3.8II-transfected but not p3.8IIxm-
transfected SMMC-7721 cells upon H2O2 exposure, sug-
gesting that HBx is also essential for HBV to promote
the loss of Mcl-1 protein (Figure 3D). To further con-
firm these in vitro findings, mice were challenged with
liver I/R treatment and Mcl-1 expression in livers of
HBx-Tg and WT mice was determined by Western blot
assay. As illustrated in Figure 3E, levels of Mcl-1 were
also found to decrease in livers of I/R-challenged HBx-
Tg mice as compared to matched controls. Additionally,
antioxidant BHA pretreatment abrogated the loss of
Mcl-1 protein in livers of I/R-treated HBx-Tg mice, sug-
gesting that HBx-mediated diminished expression of
Mcl-1 under oxidative stress conditions is mainly ROS
dependent. Collectively, HBx accelerates the loss of
Mcl-1 protein in response to oxidative stress both in
vitro and in vivo.
Reduction of Mcl-1 is involved in pro-apoptotic effect of
HBx in response to oxidative stress
To determine whether loss of Mcl-1 plays a role in HBx-
mediated apoptotic killing under oxidative stress condi-
tions, Mcl-1-expressing adenovirus (Ad-Mcl-1) and Mcl-
1-shRNA adenovirus (Ad-shMcl-1), which specific knock-
down of Mcl-1 expression, were developed (Figure 4A).
Importantly, enforced expression of Mcl-1 profoundly
attenuated caspase-3 activation and PARP cleavage in
H2O2-treated HepG2-HBx cells compared with control
cells (Figure 4B). Conversely, Adenovirus-mediated siRNA
targeting Mcl-1 gene further exacerbated the activation of
caspase-3 and cleavage of PARP in HepG2-HBx cells upon
H2O2 exposure (Figure 4C). Consistently, similar results
were also obtained in HepG2.2.15 cells in which over-
expression of Mcl-1 prevented the apoptotic cell death in
H2O2-treated HepG2.2.15 cells, while knockdown of Mcl-
1 further increased the apoptotic susceptibility of
HepG2.2.15 cells toward H2O2 stress (Figure 4D). Quanti-
fication of annexin-V-stained cells by FACS analysis
further corroborated this finding: increased apoptosis in
H2O2-treated HepG2.2.15 cells was significantly attenu-
ated by Mcl-1 over-expression (Figure 5C).
To further evaluate the role of Mcl-1 down-regulation in
HBx-mediated cell death under oxidative stress conditions
in vivo,H B x - T gm i c ew e r ea d m i n i s t e r e dM c l - 1 - e x p r e s s i n g
plasmid (p3×flag-Mcl-1) or control plasmid (p3×flag) by
tail vein injection, and Mcl-1 expression was confirmed in
livers from p3×flag-Mcl-1-treated mice (Additional file 1
Figure S1). Three days later, mice were subjected to warm
liver I/R challenge. As expected, TUNEL assay and serum
ALT and AST examination showed that I/R challenge-
induced liver injury in HBx-Tg mice was greatly improved
by Mcl-1-expressing plasmid administration (Figure 4E
and 4F). Thus, hepatocytes from HBx-Tg mice are more
susceptible to oxidative stress-induced apoptosis, at least
in part, through accelerating the loss of Mcl-1 protein.
These findings support the notion that reduction of Mcl-1
is required for pro-apoptotic effect of HBx under oxidative
stress conditions.
The caspase-3 inhibitor prevents loss of Mcl-1 in HBx-
expressing cells upon H2O2 exposure
It has been reported that caspase-3-mediated proteolysis
may contribute to diminished expression of Mcl-1 in
some cell types [32-35]. We next investigated the effects
of caspase-3 inhibitor for its ability to modulate HBx-
enhanced Mcl-1 loss. Strikingly, caspase-3-specific inhi-
bitor AC-DEVD-CHO not only prevented the activation
of caspase-3 and cleavage of PARP, but also attenuated
the loss of Mcl-1 protein in H2O2-exposed HepG2-HBx
cells in a dose-dependent manner (Figure 5A). Similarly,
incubation of cell with AC-DEVD-CHO not only pro-
tected HepG2.2.15 cells against H2O2-induced apoptosis,
but also inhibited the observed reduction in Mcl-1
expression in H2O2-treated HepG2.2.15 cells (Figure 5B
and 5C). The above experiments indicated that HBx
may trigger caspase-3-mediated Mcl-1 turnover during
H2O2 treatment because of the ability of the caspase-3
inhibitor to prevent turnover. It was therefore important
to investigate whether cleaved products of Mcl-1 could
be detected in HBx-expressing cells following H2O2
treatment and whether cleavage of Mcl-1 could be pre-
vented by caspase-3 inhibitor. Following treatment with
H2O2 for 12 hr, a band at approximately 28 kDa was
detected in HepG2-HBx cells using anti-Mcl-1 antibody,
and this may be attributed to caspase-cleaved product of
Mcl-1. Importantly, caspase-3 inhibitor AC-DEVD-CHO
prevented the appearance of this band and restored pro-
tein levels of full-length Mcl-1 in H2O2-treated HepG2-
HBx cells, suggesting that HBx triggers loss of Mcl-1
protein mainly through caspase-3-mediated cleavage
(Figure 5D). Of note, levels of this cleavage product
decreased thereafter (data not shown), in agreement
with some previous reports in some systems [34], indi-
cating that the caspase-cleaved product of Mcl-1 in
HepG2-HBx cells in this scenario may be not stable.
Thus, loss of Mcl-1 in HBx-expressing cells exposed to
oxidative stress is mainly caspase-3 dependent.
Expression of HBx and Mcl-1 is inversely correlated in
HBV-related HCC tissues
Malignant tumors, including HCC, are frequently under
persistent oxidative stress, and alterations in DNA repair
Hu et al. Molecular Cancer 2011, 10:43
http://www.molecular-cancer.com/content/10/1/43
Page 6 of 16Figure 4 Reduction of Mcl-1 is involved in pro-apoptotic effect of HBx in response to oxidative stress. (A) HepG2 cells were infected
with Ad-Mcl-1, Ad-shMcl-1 or Ad-blank (M.O.I.= 5) for 36 hr and protein levels of Mcl-1 and GAPDH were determined by Western blot assay. (B,
C and D) Cells were infected with indicated adenoviruses (M.O.I. = 5) for 36 hr followed by exposed to H2O2 (400 μM) for additional 15 hr.
Expression of PARP, caspase-3, Mcl-1, Bcl-xL, HBx and GAPDH was evaluated by Western Blot assay. “ns”, nonspecific bands. (E) HBx-Tg mice were
subjected to a single injection of Mcl-1-expressing plasmid (p3×flag-Mcl-1) or control plasmid (p3×flag) by tail vein using a hydrodynamics-based
procedure (see “Materials and Methods”). Three days later, mice were challenged with liver I/R. Livers were collected and subjected to TUNEL
and H.E. staining. Representative results are shown. Magnification, ×100. (F) Mice were treated as in Fig. 4E and circulating levels of serum ALT
and AST were analyzed. Results are mean ± SD (n = 4). *, p < 0.05.
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Page 7 of 16Figure 5 The caspase-3 inhibitor prevents loss of Mcl-1 in HBx-expressing cells upon H2O2 exposure. (A and B) Cells were treated with
or without indicated amount of AC-DEVD-CHO for 5 hr followed by exposed to H2O2 (400 μM) for additional 15 hr. Expression of PARP,
caspase-3, Mcl-1, Bcl-xL, HBx and GAPDH was determined by Western Blot assay. “ns”, nonspecific bands. (C) Cells were infected with indicated
adenoviruses (M.O.I. = 5) for 36 hr or treated with DMSO or AC-DEVD-CHO (80 μM) for 5 hr followed by exposed to H2O2 (400 μM) for
additional 15 hr. The extent of apoptosis was evaluated by FACS analysis. Representative results are shown. Plots (lower panel) are mean ± SD of
data from three independent experiments. *, p < 0.05. “AC”, AC-DEVD-CHO. (D) Cells were treated with DMSO or AC-DEVD-CHO (80 μM) for 5 hr
followed by exposed to H2O2 (400 μM) for additional 12 hr. Expression of Mcl-1 was determined by Western Blot assay. A band at about 28 kDa
indicates the cleaved form of Mcl-1.
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indicators of oxidative damage [36,37]. To evaluate the
potential relationship between HBx and oxidative stress
in HBV-related HCC tissues, expression of HBx, DNA
repair enzyme human MutT homolog 1 (hMTH1) and
antioxidant enzyme manganese superoxide dismutase
(MnSOD) was analyzed in HBV-positive HCC tissues.
As illustrated in Figure 6A, a positive correlation
between HBx and hMTH1 mRNA expression was
observed in 22 HCC samples (r = 0.38, p = 0.039). In
addition, HBx mRNA expression was also significantly
correlated to MnSOD mRNA expression in these HCC
samples (r = 0.46, p = 0.015) (Figure 6B). These results
s u g g e s tt h a tt h e r em a yb eac o r r e l a t i o nb e t w e e nH B x
expression and the extent of oxidative damage in HBV-
positive HCC tissues.
To further examine the relationship between HBx and
anti-apoptotic Bcl-2 family members in HBV-related
HCCs, protein levels of Mcl-1 and Bcl-xL in HBV-posi-
tive HCC tissues were evaluated by Western blot analysis
(Figure 6C). Since HBx protein was hardly detectable in
HCC tissues, HBx expression was determined by its
mRNA levels. As expected, HBx mRNA expression was
f o u n dt ob ei n v e r s e l yc o r r e l a t e dw i t hM c l - 1p r o t e i n
expression in 30 HCC samples (r = 0.40, p = 0.028) How-
ever, no correlation was observed between HBx and Bcl-
xL expression (r = 0.20, p = 0.285) (Figure 6D). Taken
together, these histological observations, along with the
above findings, suggest a potential pathophysiological
role of Mcl-1 in HBV-associated hepatocarcinogenesis.
Discussion
Persistent oxidative stress has been suggested to be a
major contributor to the development of HCC as it can
exert multiple pro-tumorigenic effects, including altered
gene expression [38], epigenetic modulations [37],
enhanced hepatocyte death and IL-1a release [29],
genomic instability [39] as well as higher DNA mutation
rates [40]. Given the critical role of HBx in the patho-
genesis of HBV-related liver cancer [1,2] and Mcl-1 in
liver homeostasis [25,26,41], the purpose of this study
was to determine whether the apoptotic susceptibility of
hepatocytes under oxidative stress conditions could be
disturbed by HBx and the potential role of Mcl-1 in this
process.
In the present study, the concentration of H2O2 we
used did not induce apparent apoptosis in control hepa-
tocytes, while it did trigger significant apoptotic killing
in HBx-expressing hepatocytes. Consistently, no major
injury was detected in WT control mice following liver
I/R challenge, while severe liver cell death were observed
in HBx-Tg mice receiving the same treatment. Further-
more, HBV-replicating HepG2.2.15 cells and SMMC-
7721 cells transfected with the wild-type, but not HBx-
mutated, HBV genome unanimously exhibited increased
apoptotic susceptibility to H2O2 stress. These in vitro
and in vivo data clearly demonstrated that HBx expres-
sion sensitized hepatocytes to oxidative stress-mediated
cell killing. Our findings agree with the majority results
of previous observations which showed that HBx
increases susceptibility of hepatocytes to a variety of
apoptotic stimuli [7-12], although there are opposite
data about the effects of HBx protein on apoptotic sig-
nals [2,42]. The discrepant activity of HBx on apoptosis
may result from the different stages of natural HBV
infection. It is possible, as proposed by Arbuthnot P and
his colleagues [43], that HBx inhibits apoptosis at early
stage during hepatocyte infection in order to facilitate
HBV replication, while promotes apoptosis at later stage
to accelerate virus spread.
Recent work showed that HBx mainly localizes in the
mitochondria, disturbs mitochondrial membrane potential
and subsequently increases ROS production, suggesting
that HBx has an ability to activate mitochondria-depen-
dent apoptosis. Given the critical role that anti-apoptotic
Figure 6 Expression of HBx and Mcl-1 is inversely correlated in
HBV-related HCC tissues. (A) The correlation of HBx and hMTH1
mRNA expression and (B) HBx and MnSOD mRNA expression in 22
HBV-positive HCC samples was shown. (C) Protein levels of Mcl-1,
Bcl-xL and b-actin were determined by Western blot assay in 18
HBV-positive HCC samples. The relative protein expression of Mcl-1
and Bcl-xL was quantified and normalized to b-actin. The relative
mRNA expression of HBx was also quantified and normalized to 18S
rRNA. (D) The relationship between HBx and Mcl-1 expression or
HBx and Bcl-xL expression in 30 HBV-positive HCC samples was
shown. Correlation between two variables was calculated by
Spearman rank correlation coefficient (r).
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sis control [18,19], we went further to examine the expres-
sion of anti-apoptotic Bcl-2 members. Bcl-xL and Mcl-1
have been identified as major anti-apoptotic Bcl-2 proteins
in the liver for previous studies revealed that Bcl-2 is not
generally expressed in human hepatocytes and hepatoma
cell lines [31]. Both of these proteins play a crucial role for
the maintenance of mitochondrial membrane integrity.
They mainly localize at the outer membrane of mitochon-
dria, prevent the oligomerization and the activation of
multidomain pro-apoptotic proteins Bax and Bak [44,45].
In addition, they can also inhibit apoptosis by sequestering
pro-apoptotic BH3-only proteins such as Bid, Bim or
Puma [46]. Interestingly, however, only protein levels of
Mcl-1 were found to decrease significantly in HBx-expres-
sing cell lines and livers of HBx-Tg mice upon oxidative
stress stimulation, while no major changes in Bcl-xL levels
were observed. Consistently, analysis from clinical samples
also revealed an inverse correlation between the expres-
sion of HBx and Mcl-1, but not Bcl-xL, in HBV-related
HCC tissues. Thus, these results argue against the involve-
ment of Bcl-xL in HBx-mediated cell killing in response to
oxidative stress and suggest that different anti-apoptotic
Bcl-2 members may not functionally equivalent under cer-
tain conditions [46,47]. Furthermore, similar results were
also obtained in HepG2.2.15 cells as well as p3.8II-trans-
fected but not p3.8IIxm-transfected SMMC-7721 cells.
Consistent with a previous report [48], we also observed a
mild increase in Mcl-1 protein levels in unstimulated
HepG2-HBx cells compared with those in HepG2-con
cells, and this may be due to the transactivation effects of
HBx. Nevertheless, upon H2O2 exposure, levels of Mcl-1
declined significantly in HepG2-HBx cells as compared to
matched controls, indicating that rapid loss of this highly
regulated protein may be involved in HBx-mediated cell
killing. Indeed, enforced expression of Mcl-1 provided
long-term protection against HBx-induced apoptosis.
Conversely, specific knockdown of Mcl-1 expression
further exacerbated HBx-induced apoptosis. It should be
noted that the protection effect of Mcl-1 over-expression
was relatively weaker than that of caspase-3 inhibition,
indicating that down-regulation of Mcl-1 may not be the
exclusive pathway that mediates the pro-apoptotic activity
of HBx.
Ahmad KA and colleague have demonstrated that Bax
plays an important role in H2O2-induced apoptosis via
mitochondrial translocation [49], meanwhile Mcl-1 has
been shown to interact with Bak and prevent its translo-
cation to the mitochondria [44,45]. We therefore exam-
ined the expression and mitochondrial translocation of
Bax/Bak in our system. Although H2O2 did trigger the
translocation of Bax/Bak from the cytosol to the mito-
chondria, a reduced expression of Bax/Bak was observed
in both the whole cell lysates and their mitochondria
fractions of HBx-expressing cells as compared to
matched control cells (Additional file 1 Figure S2),
which appears to be inconsistent with the previous
report [49]. Nevertheless, we speculated that, after 15 hr
of treatment with H2O2, HBx-expressing cells may
undergo relatively late-stage apoptosis, which may lead
to protease hydrolysis of Bax/Bak or trigger some poten-
tial mechanisms to dysregulate their expression. These
observations are in agreement with an earlier study [50].
Moreover, the cleavage of Bax was also detected under
this condition (data not shown). As we did not examine
the expression and mitochondrial translocation of Bax/
Bak at earlier intervals, it is unlikely to rule out the pos-
sible involvement of Bax or Bak in HBx-enhanced cell
death, yet, our findings strongly support the notion that
Mcl-1 plays a functional role in HBx-mediated apoptotic
killing under oxidative stress conditions.
Expression of Mcl-1 is tightly controlled through
diverse signaling pathways. Results of the present study
identified the association of Mcl-1 down-regulation with
caspase activation, as caspase-3 inhibitor AC-DEVD-
CHO not only blocked HBx-mediated apoptosis but also
significantly attenuated the observed reduction of Mcl-1
expression in ROS-exposed HBx-expressing cells. These
findings are consistent with our previous study, which
demonstrated that HBx protein renders hepatocytes sus-
ceptible to chemotherapeutic agent cisplatin through sti-
mulating oxidative stress-dependent caspase-3-mediated
degradation of Mcl-1 [30]. Moreover, in this study, we
further showed that HBx actually has the ability to sen-
sitize hepatocytes to oxidative signals per se-induced
apoptosis, and that this pro-apoptotic effect of HBx was
also mediated through accelerating caspase-3-dependent
loss of Mcl-1 protein. Furthermore, we also detected a
caspase-cleaved product of Mcl-1 in H2O2-treated
HepG2-HBx cells, as this cleavage of Mcl-1 could be
prevented by caspase-3 inhibitor. Given these observa-
tions, we propose that caspase-3-mediated degradation
of Mcl-1 may represent a common mechanism during
pro-oxidant stimuli-induced apoptosis in HBx-expres-
sing cells.
Of note, although caspase-3 inhibitor greatly pre-
vented Mcl-1 loss in H2O2-treated HepG2-HBx cells, it
did not completely restore its protein levels as compared
to unstimulated HepG2-HBx cells (Figure 5D), indicat-
ing that other mechanism may also contribute to reduce
Mcl-1 expression. Inoshita S and coworkers [28]
reported that short-term exposure (1~3 hr) of HEK293
and PAE cells to hydrogen peroxide results in JNK acti-
vation, which leads to apoptosis through phosphoryla-
tion and inactivation of Mcl-1, while they did not
explore the effect of long-term H2O2 exposure on Mcl-1
expression. In the present study, we noticed that over
12 hr exposure of HBx-expressing hepatocytes to H2O2
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and we also observed sustained activation of JNK in this
setting (data not shown). As the ability of HBx to acti-
vate JNK pathway has been reported by several groups
[51,52], future study should be warranted to determine
the possible involvement of JNK signaling in HBx-trig-
gered loss of Mcl-1 protein.
The observation that caspase-3 inhibitor prevented the
loss of Mcl-1 protein in H2O2-exposed HBx-expressing
cells indicates that although Mcl-1 mainly functions
upstream of caspases, the major regulation of Mcl-1 by
HBx following H2O2 treatment lies downstream of cas-
pase-3. Thus, the reduction of full-length Mcl-1 protein
levels due to caspase-3-mediated proteolysis represents a
secondary rather than a primary event in the induction
of cell death. We suppose that, under oxidative stress
conditions, HBx may activate caspase-3 signaling
through a Mcl-1-independent mechanism, and activated
caspase-3 triggers down-regulation of full-length Mcl-1
protein through proteolysis, thus resulting in the impair-
ment of the inhibitory effect of this anti-apoptotic mole-
cule on mitochondria-dependent apoptosis and
subsequent caspase-3 activation. As a result, caspase-3
cascade is further activated in a positive feedback loop,
allowing the irreversible commitment to cell death.
Recently, caspase-mediated proteolysis of Mcl-1 has
been confirmed by several independent groups [32-35],
however, it remains unclear whether the caspase-3 clea-
vage sites in Mcl-1 protein in HBx-expressing hepato-
cytes are still the same (Asp127 and Asp157) as
reported previously [33], future studies based on site-
directed point mutations and sequence analysis would
help to address this issue. Moreover, it will be important
to elucidate which signaling pathway is responsible for
HBx-mediated caspase-3 activation under oxidative
stress conditions.
In line with several previous reports [9,53], a slightly
increased level of oxidative stress was observed both in
unstimulated HepG2-HBx and HepG2.2.15 cells as well
as livers of HBx-Tg mice as compared to their respec-
tive controls. Strikingly, upon moderate oxidative stress
stimulation, HBx greatly enhanced the extent of oxida-
tive stress, which was accompanied by a significant
increase in the rate of apoptosis in HBx-expressing cells
both in vitro and in vivo. Thus, HBx protein and oxida-
tive signals may synergize to augment cellular ROS
accumulation up to a deleterious level resulting in
apparent liver injury. Antioxidant treatment effectively
abrogated the loss of Mcl-1 protein and cell death in
HBx-expressing cells, suggesting that pro-apoptotic
effect of HBx under oxidative stress conditions is mainly
ROS dependent. The fact that HBx-mediated cell killing
was not apparent until moderate pro-oxidant stimuli
were administrated indicates that a certain threshold of
ROS level would be required to trigger apoptosis and
that HBx itself may not be sufficient to initiate apoptotic
event, but rather function as an apoptosis inducer under
stress conditions [9,47]. Thus, results of the present
work highlighted the importance of ROS accumulation
in the pro-apoptotic activity of HBx, nevertheless, the
exact mechanism by which HBx significantly stimulates
cellular ROS production remains to be elucidated.
Controlled hepatocyte apoptosis is essential for liver
homeostasis. However, uncontrolled apoptosis can
induce compensatory proliferation of hepatocytes
[25,26]. Although the ideas that increased hepatocyte
apoptosis can cause liver cancer are seemingly inconsis-
tent with the known phenomenon of apoptosis resis-
tance of pre-malignant and malignant hepatocytes,
uncontrolled hepatocyte apoptosis can lead to compen-
satory hepatocyte proliferation and cause HCC in animal
model [26]. It is known that chronic viral hepatitis is
characterized not only by inflammation, but also by an
increased rate of apoptosis and elevated caspase activ-
ities to preserve homeostasis after tissue damage [54].
Therefore, it is likely that, as has been suggested by
others [7], enhanced hepatocyte death triggered by HBx
may promote the induction of liver cell growth factors,
which in turn enhance compensatory hepatocyte prolif-
eration, not only creating a larger reservoir of new unin-
fected hepatocytes to propagate the viral infection but
also contributing to the development of HCC.
Mcl-1 was found to be highly expressed in human
HCC, and has been implicated in the apoptosis resis-
tance of HCC cells [23,24]. Thus, Mcl-1 seemingly plays
a contradictory role in hepatocarcinogenesis. However,
the role that Mcl-1 plays in HCC promotion and pro-
gression may depend on the milieu. It has long been
known that chronic inflammation and tumor tissues are
frequently under oxidative stress [14,55,56]. Hence, it is
possible that, on one side, acceleration of Mcl-1 loss in
HBV-infected hepatocytes under moderate or sublethal
oxidative stress conditions may result in a pro-apoptotic
environment provoking compensatory proliferation,
finally giving rise to the outgrowth of the neoplastic cell
population and contributing to the initiation of liver
cancer [26]. On the other side, malignant hepatocytes
that over expresses Mcl-1 can be selected during tumor
progression and eventually confer resistance of HCC
cells to apoptosis triggers. Our findings are also in
agreement with a tumor promoting effect of a pro-oxi-
dant intracellular milieu. For example, Clément MV and
his groups demonstrated that overexpression of Bcl-2
increases intracellular O2
- and inhibits apoptotic acidifi-
cation and cell death, while decrease in intracellular
superoxide sensitizes Bcl-2-overexpressing tumor cells
to apoptotic killing [57]. Consistently, Pervaiz, S and
coworkers reported that GTP-binding protein Rac
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tumor cell response to apoptosis, conversely, inhibition
of the Rac pathway causes a decrease in superoxide
anion concentration, resulting in a significant increase
in tumor cell sensitivity to apoptosis [58].
Conclusions
In conclusion, we provide both in vitro and in vivo evi-
dence that HBx has the ability to enhance the suscept-
ibility of hepatocytes toward oxidative stress-induced
apoptotic killing by accelerating the loss of Mcl-1 pro-
tein, which is mainly caspase-3 dependent. Therefore,
tissue microenvironments generating ROS such as
chronic inflammation and injury may aggravate the
pathogenesis of HBV-related liver disease by provoking
cell death.
Materials and methods
Antibodies and Reagents
The primary antibodies specific for Mcl-1 (S-19 and K-
20), Bax (N-20) and Bak (N-20) were purchased from
Santa Cruz Biotechnology. Antibodies for Bcl-xL, Bcl-2,
Caspase-3, PARP, GAPDH and Myc-tag were from Cell
Signaling Technology (CST). Purified anti-Mcl-1 anti-
body was from Biolegend. Rabbit polyclonal anti-HBx
antibody was generated in our laboratory. peroxide
hydrogen (H2O2), butylated hydroxyanisole (BHA), 4’,6’-
Diamidino-2-phenylindole (DAPI) were from Sigma-
Aldrich; AC-DEVD-CHO were from Calbiochem.
Cell Lines and Cell Culture
HepG2, Huh-7 and HEK293A cell lines were obtained
from American Type Culture Collection (Manassas,
VA). SMMC-7721 and HepG2.2.15 cell lines were from
the Cell Research Institute of Chinese Academy of
Sciences (Shanghai, China). Cells were maintained at 37°
C in a humidified incubator containing 5% CO2 in Dul-
becco’s modified Eagle’s medium supplemented with
10% heat-inactivated fetal bovine serum and passed
every 2-3 d to maintain logarithmic growth.
Plasmids and Recombinant Adenovirus Preparation
The Myc-tagged full-length HBx plasmid (pcDNA3.1-
HBx-myc) was constructed by inserting a PCR-amplified
full-length HBx fragment into the EcoRI/KpnI sites of
pcDNATM3.1/myc-His(-)A (Invitrogen), using the pri-
mers, forward, 5’-CGGAATT-CATGGCTGCTAGG
CTGTGCTG-3’ and reverse, 5’-GGGGTACCGGCAGA-
GGTGAAAAAGTTGC-3’. The Mcl-1-expressing plas-
mid (p3×flag-Mcl-1) was generously provided by Prof.
Wu Mian (University of Science and Technology of
China, Hefei, China). The control (Ad-blank), Myc-
tagged HBx-expressing (Ad-HBx-myc), Mcl-1-expressing
(Ad-Mcl-1) and Ad-shMcl-1 (harboring Mcl-1-small
hairpin RNA, Mcl-1-shRNA) recombinant adenoviruses
were generated as described previously [30]. The pri-
mers were as follows: pAd-HBx-myc, forward, 5’-CGG-
AATTCATGGCTGCTAGGCTGTGCTG-3’; reverse, 5’-
GAAGATCTAAGCT-GGAGACCGTTTAAAC-3’;p A d -
Mcl-1, forward, 5’-GGAATTCATGTTTGGC-CTCAAA
AGAAACGCGG-3’; reverse, 5’-CGGGATCCGTCAAC
TATTGCACTT-ACAGTAAGG-3’.M c l - 1 - s h R N Aw a s
generated using the pSUPER RNAi System™ (Promega).
The Mcl-1 siRNA sequence used was included in the
following sense and antisense oligonucleotides: 5’-
GATCCCCCGGGACTGGCTAGTTAAACTTC-AAGA
GAGTTTAACTAGCCAGTCCCGTTTTTA-3’ and 5’-
AGCTTAAAAAC-GGGACTGGCTAGTTAAACTCT
CTTGAAGTTTAACTAGCCAGTCCCGGGG-3’.S e n s e
and antisense strands were annealed and ligated into the
linearized pSUPER.neo+GFP Vector following the man-
ufacturer’s directions. All the constructs were confirmed
by DNA sequencing and Western blot analysis. The
recombinant adenovirus was generated in HEK293A
cells by homologous recombination system. Adenovirus
was purified using Adeno-X™ Virus Purification Kit
(Clontech Laboratories). The titer of the virus was
determined using Adeno-X™ Rapid Titer Kit (Clontech
Laboratories) following the manufacturer’s instructions.
Transient transfection
SMMC-7721 cells were transiently transfected using PEI
(Polyplus; AFAQ) as described previously [59].The plas-
mid p3.8II containing the wild-type HBV genome and
p3.8IIXm consisting of an HBx-mutated HBV genome
were kindly provided by Prof. Zhao Mujun (Institute of
Biochemistry and Cell Biology, Shanghai Institutes for
Biological Sciences, Chinese Academy of Sciences,
Shanghai, China) [3].
Semi-Quantitative and Real-Time Reverse Transcription-
PCR
Total RNAs were isolated from cells or HCC samples
using TRIzol Reagent (Invitrogen) following the manu-
facturer’s instructions. The complementary DNA tem-
plate was prepared using random primers and Moloney
Murine Leukemia Virus reverse transcriptase (Promega)
according to the manufacturer’s protocol. After the
reverse transcription reaction, the complementary DNA
template was either semi-quantitated by reverse tran-
scription-PCR (RT-PCR) or quantitated using real-time
PCR technology. The primers used in this study are as
follows: HBx (AY310322) forward, 5’-ATGGCTGC
TAGGCTGTGCTG-3’;r e v e r s e ,5 ’-GGCAGAGGTGAA-
AAAGTTGC-3’; hMTH1 (AK026631) forward, 5’-AGC
CTCAGCGAGTTCT-CCTG-3’; reverse, 5’-GATCTGG
CCCACCTTGTGC-3’; hMnSOD (Y00472) forward, 5’-
GAGATGTTACAGCCCAGATAGC-3’;r e v e r s e ,5 ’-
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(NR_003286) forward, 5’-CGGCTACCACATCCAAG-
GAA-3’;r e v e r s e ,5 ’-GCTGGAATTACCGCGGCT-3’.
18srRNA was used as a control. Each sample was tested
in duplicate.
Western Blot Analysis
Western blotting was performed as described previously
[60]. Briefly, whole-cell extracts or tumor specimens
were prepared in lysis buffer [Tris-HCl (20 mM), pH
7.4, NaCl (150 mM), glycerol (10%), Nonidet P-40
(0.2%), EDTA (1 mM), EGTA (1 mM), PMSF (1 mM),
NaF (10 mM), aprotinin (5 mg/ml), leupeptin (20 mM),
and sodium orthovanadate (1 mM)] and centrifuged at
12,000 g for 15 min. Protein concentrations were mea-
sured using the BCA assay. Immunoblotting was per-
formed using specific primary antibodies and
immunocomplexes were incubated with the appropriate
horseradish-peroxidase-conjugated secondary antibodies
or fluorescein-conjugated secondary antibody, and then
detected using the ECL kit (Santa Cruz Biotech) or
Odyssey fluorescence scanner (Li-Cor, Lincoln, NE).
Reactive Oxygen Species and Glutathione Measurement
Production of ROS was measured with the fluorogenic
dye 2’,7 ’-dichloro-fluorescin diacetate (DCFH-DA), a
cell permeant compound, using Reactive Oxygen Species
Assay Kit (Invitrogen). Briefly, Cells were preincubated
with DCFH-DA (10 μM) for 30 min at 37°C. After the
extracellular dye was removed, the cells were washed 3
times and incubated with serum-free DMEM. Subse-
quently, fluorescence was measured at 488 nm excita-
tion and 525 nm emission using a fluorescence
microscope (Olympus). Total liver glutathione (GSH)
content were determined by a commercial kit (Jian-
cheng, Nanjing, China) according to the manufacturer’s
protocol. GSH and GSSG Levels were measured using a
GSH and GSSG Assay Kit (Beyotime, China). Liver in
situ ROS production were determined by staining frozen
liver sections with dihydroethidine (DHE) (Invitrogen),
whose oxidation leads to the fluorescent derivative ethi-
dine [29].
Apoptosis Analysis
For apoptosis analysis, cells were seeded into 6-well
plates with 5 × 10
5 cells/well and incubated overnight
followed by treatment with or without H2O2. The extent
of apoptosis was determined by FACS analysis (Beck-
man Coulter) using Annexin V Apoptosis Detection Kit
(Invitrogen). Apoptotic cells in the liver were detected
by terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) staining using In Situ Apoptosis
Detection Kit (Calbiochem), and the nucleus was coun-
terstained with methyl green.
Preparation of cytosolic and mitochondria fractions
Preparation of cytosolic and mitochondria fractions was
achieved using a commercially available cytosol/mito-
chondria fractionation kit according to the manufac-
turer’s protocol (Beyotime, China). Briefly, 1 × 10
7 cells
were washed with ice-chilled PBS at 1,200 g. Cell pellets
were resuspended in 500 μL of extraction buffer and
incubated at 4°C for 20 minutes, followed by homogeni-
zation. The homogenate was centrifuged at 1,000 g for
10 minutes at 4°C. The supernatant was additionally
centrifuged at 3,500 g for 10 minutes (fraction enriched
with intact mitochondria). The supernatant from the
last centrifugation was used as the cytosolic fraction and
the final pellet represents a more purified mitochondrial
fraction.
Liver Ischemia
HBx transgenic mice were kindly provided by Prof. Yang
Xiao (Genetic Laboratory of Development and Diseases,
Institute of Biotechnology, Beijing, China). The identifi-
cation of HBx transgenic mice was performed as
described previously [61]. A nonlethal model of segmen-
tal (70%) hepatic warm ischemia was used. All struc-
tures in the portal triad (hepatic artery, portal vein, bile
duct) to the left and median liver lobes were occluded
with a microvascular clamp for 60 min; reperfusion was
i n i t i a t e db yr e m o v a lo ft h ec l a m p .A tt h ee n do ft h e
observation period, mice were sacrificed by cervical
dislocation.
In Vivo Gene Expression Experiments
Plasmid DNA was administered into mice by a hydrody-
namic-based gene transfer technique via rapid injection
of a large volume of DNA solution through the tail vein,
as described elsewhere [62]. Briefly, 20 μg Mcl-1-expres-
sing plasmid (p3×flag-Mcl-1) or control plasmid
(p3×flag) was diluted in 1.8 ml of saline and injected by
tail vein into the circulation within 5 to 10 s. Three
days later, mice were treated with 60 min of warm liver
ischemia followed by 6 hr of reperfusion challenge
before sacrificed. Part of the liver was processed for
TUNEL-based immunohistochemistry and hematoxylin
and eosin (HE) staining and the remaining liver was
immediately frozen in liquid nitrogen and stored at -80°
C for tissue lysate preparation. All animals received
human care according to the criteria outlined in the
Guide for the Care and Use of Laboratory Animals [63].
Aminotransferase Levels
About 100 μl of blood was collected from the tail vein.
Alanine aminotransferase (ALT) and aspartate amino-
transferase (AST) were measured in the Division of
Clinical Laboratory of Eastern Hepatobiliary Surgery
Hospital by standard procedures.
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Liver specimens were obtained from primary HCC
patients with HBV infection who received surgical resec-
tion in Eastern Hepatobiliary Surgery Hospital of the
Second Military Medical University (Shanghai, China)
with the approval of The Human Research Committee
of University and with the patients’ consents.
Statistical Analysis
Results are expressed as mean ± SD. Statistical evalua-
tion was carried out by one-way analysis of variance
(ANOVA) followed by Student-Newman-Keuls test.
Correlation between two variables was calculated by
Spearman rank correlation coefficient. A value of p <
0.05 was considered to be statistically significant.
Additional material
Additional file 1: Figure S1 -The expression of flag-Mcl-1 in whole
liver extracts. HBx-Tg mice were subjected to a single injection of Mcl-
1-expressing plasmid (p3×flag-Mcl-1) or control plasmid (p3×flag) by tail
vein. Two days later, whole liver extracts were probed with ant-Flag
antibody. Figure S2 -The expression and mitochondria translocation of
Bax/Bak in HBx-expressing cells following H2O2 treatment. (A) Indicated
cells (1 × 10
7) were treated with or without H2O2 (400 μM) for 15 hr
followed by subjected to cellular fractionation. Whole cell lysates,
cytosolic and mitochondrial fractions were subjected to Western blot
analysis and probed with anti-Bax or anti-Bak antibody. (Cyto: cytosolic;
Mito: mitochondrial). (B) SMMC-7721 cells were transiently transfected
with p3.8II or p3.8IIxm for 36 hr followed by treated with H2O2 (400 μM)
for additional 15 hr. Then whole cell lysates, cytosolic and mitochondrial
fractions were subjected to Western blot assay and probed with
indicated antibodies. (Cyto: cytosolic; Mito: mitochondrial).
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